TMDX Q4 2022 Earnings — TransMedics Group, Inc. Revenue & Financial Results | Market Cap Arena

TMDXTransMedics Group, Inc.

$5B

Q4 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$31M+224.5% YoY

Gross Profit

$21M66.0% margin

Operating Income

-$7M-21.6% margin

Net Income

-$7M-21.4% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

+22.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$7M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$277M

Total Liabilities

$90M

Stockholders' Equity

$187M

Cash & Equivalents

$201M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$31M	$10M	+224.5%
Gross Profit	$21M	$7M	+196.3%
Operating Income	-$7M	-$11M	+40.2%
Net Income	-$7M	-$13M	+47.0%

Geographic Segments

UNITED STATES

$29M93%

Other Countries

$2M7%